Journal Article

PreJuSER-12540

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Temperature and Bias Effects on Sputtered Ceria Diffusion Barriers for Solid Oxide Fuel Cells

Fonseca, F. C. ; Uhlenbruck, S.FZJ* ; Nédélec, R.FZJ* ; Sebold, D.FZJ* ; Buchkremer, H. P.FZJ*

2010
Electrochemical Society Pennington, NJ

This record in other databases:  

Please use a persistent id in citations: doi:10.1149/1.3476296

Abstract: This open-label extension evaluated the long-term efficacy and tolerability of rufinamide in patients with Lennox-Gastaut syndrome (LGS) who had previously completed a 12-week double-blind study.In total, 124 patients (aged 4-37 years), receiving 1-3 concomitant antiepileptic drugs, were treated with rufinamide approximately 25-60 mg/kg/day. Efficacy was assessed by seizure frequency; tolerability by adverse events (AEs) and laboratory tests.Overall, patients were treated with rufinamide for a median (range) of 432 (10-1149) days. Reductions in seizure frequency were observed throughout the study; during the last 12 months of treatment, 41.0% and 47.9% of patients had > or = 50% reduction in total and tonic-atonic seizure frequency, respectively. The most common AEs were vomiting (30.6%) and pyrexia (25.8%).In this open-label extension, rufinamide appeared to be an effective long-term adjunctive therapy for the treatment of LGS-associated seizures in children and young adults.

Keyword(s): J

Note: F.C.F. is thankful for the Brazilian agencies FAPESP (2007/08686-8) and CNPq (306422/2007-7). Thanks also to F. Vondahlen for helping us with PVD depositions and W. Herzhof and K. Portulidou for sample supplying/cathode depositions.

---

Contributing Institute(s):

1. Werkstoffsynthese und Herstellverfahren (IEK-1)

Research Program(s):

1. Rationelle Energieumwandlung (P12)
2. SOFC - Solid Oxide Fuel Cell (SOFC-20140602) (SOFC-20140602)

Appears in the scientific report 2010

---